Suzhou Zhide Cloud Chuang Intelligent Co., Ltd.

Both parties have initiated comprehensive cooperation, involving IVD business, non-public and group customer business, supply chain business, orthopedics, and channel integration ..

Start comprehensive strategic cooperation

This afternoon (March 11th), according to the official WeChat account of Jiuzhou Tong Medical Equipment, a strategic business docking meeting between Jiuzhou Tong Medical Equipment Group and Mindray Group was held in Shenzhen. It is reported that this strategic business docking is another in-depth strategic cooperation between Jiuzhou Tong Medical Equipment Group and Mindray Group based on their previous cooperation. Mr. Gong Yihua and Mr. Li Zaiwen jointly signed a comprehensive strategic cooperation agreement.

The leaders of Jiuzhou Tong Medical Equipment Group include Mr. Gong Yihua, Chairman, Mr. Fu Xiong, General Manager, Mr. Sun Yanbing, Senior Vice General Manager, Mr. Liu Hua, Director of IVD Business Development Department, Mr. Yan Lei, Director of Channel Management Department, Ms. Shi Wei, Deputy Director of IVD Business Development Department, and Mr. Wan Li, Service Manager of IVD Business Development Department.

The leaders of Mindray Group include Mr. Li Zaiwen, Senior Vice President, Mr. Feng Xuanyun, General Manager of Marketing in China, Mr. Luo Xiaoliang, General Manager of In Vitro Diagnostic Product Marketing Management in China, Mr. Zhang Yun, General Manager of Non Public Customer Marketing Management in China, Mr. Qi Min, Director of Channel Development and Management in China, Mr. Zhao Ligang, In Vitro Diagnostic Product Operations Manager of Product Line and Customer Line Operations Management, Mr. Lei Tao, In Vitro Diagnostic Product Line Channel Manager of Channel Development and Management in China, and Mr. Li Xuan, Market Research Manager of Public Customer Department in China.

The official WeChat account pointed out that for the business cooperation between the two parties in 2021, it will be carried out from the aspects of IVD business, non-public and group customer business, supply chain business, orthopedics, channel integration, etc.

At present, the medical device business is a rapidly developing business segment of Jiuzhou Tong in recent years, which is expected to develop into a sector that is on par with Jiuzhou Tong's existing pharmaceutical business.

According to the announcement from Jiuzhou Tong, the company's medical equipment and family planning products business maintained a high-speed growth momentum in the first half of 2020, achieving sales revenue of 10.263 billion yuan, an increase of 43.04% compared to the same period last year; The gross profit margin of sales in the first half of the year was 9.07%, a significant increase of 1.84 percentage points compared to the same period last year.

Due to the impact of the epidemic, there is a strong demand for protective materials both domestically and internationally, resulting in a significant increase in sales and gross profit of the equipment business as a whole.

Operating over 240000 medical device varieties

Jiuzhou Tong Medical Equipment Group Co., Ltd. is a wholly-owned subsidiary of Jiuzhou Tong established on October 17, 2015. Relying on the strong platform advantages of Jiuzhou Tong Pharmaceutical Group, we currently have 19 wholly-owned medical device companies, 25 joint venture medical device companies, and 2 industrial companies nationwide. We also have medical device departments in 60 subsidiaries of Jiuzhou Tong Pharmaceutical Group, over 480 distribution points, and more than 20 logistics distribution centers.

At present, there are four sales channels: medical channels, distribution channels, OTC channels, and e-commerce. The main business scope covers six product lines: medical equipment, testing reagents, high-value consumables, household appliances, family planning products, and conventional consumables; Operating over 50000 types of product specifications; Serving over 60000 terminal cooperative stores, 43000 medical clients, and more than 10000 commercial clients.

At the hospital terminal, the main business models include general manager and general agent, channel distribution, hospital direct distribution, centralized distribution, financial leasing, laboratory packaging, and delivery services. We also provide customers with supply chain solutions such as logistics platforms, third-party logistics, commissioned distribution, and in-hospital smart logistics, as well as platform sharing solutions such as business partners, crowdfunding models, and bidding resource sharing systems.

Jiuzhou partners with global logistics companies

A week ago, Jiuzhou Tong Logistics announced that it had signed a strategic cooperation agreement with Deutsche Bahn. Under the framework of strategic cooperation between the two parties, Jiuzhou Tong will rely on the global logistics resources of Deutsche Bahn to promote the development of its domestic and international pharmaceutical logistics business.

Public information shows that Deutsche Bahn Group is one of the world's largest logistics companies, with over 78000 employees in 1400 locations in more than 100 countries worldwide. From sea, air, land, to contract logistics, it holds a leading market position and focuses on providing integrated logistics solutions.

Dexin Group operates in over 25 countries worldwide and has more than 100 international clients in related industries, covering fields such as pharmaceuticals, medical devices, and medical products. It is reported that both parties will establish in-depth cooperation in multiple fields including professional warehousing, domestic distribution, international trade and logistics.

Dexin will be able to leverage the existing domestic medical industry qualifications of Jiuzhou Tong and access the pharmaceutical warehousing and transportation distribution network resources composed of Jiuzhou Tong's GSP (Good Manufacturing Practice) certification operation sites throughout the country, thus opening up a situation in the fields of Chinese medicine (13.870, -0.07, -0.50%) and medical product logistics.

Zhang Qingsong, General Manager of Jiuzhou Tong Pharmaceutical Group Logistics Co., Ltd., said, "As an international leading logistics enterprise with a mature pharmaceutical logistics network, Dexin can provide reliable logistics solutions in the fields of international air and sea transportation and overseas contract logistics, thereby accelerating the expansion of Jiuzhou Tong and its customers in overseas markets.

Jiuzhou Tong was established in March 1999. It is a large enterprise group mainly engaged in Western medicine, traditional Chinese medicine, and medical equipment, with medical institutions, wholesale enterprises, and retail pharmacies as its main customer targets, and providing customers with value-added services such as information and logistics.

Jiuzhou Tong has a nationwide marketing network and abundant upstream and downstream resources. It has successively built 31 provincial-level subsidiaries (large pharmaceutical logistics centers) and 104 prefecture level subsidiaries (regional distribution centers) in most regional center cities and provincial capital cities such as Hubei, Beijing, Henan, Xinjiang, Shanghai, Guangdong, etc., and established a marketing network covering more than 95% of administrative regions across the country.

At present, we operate over 410000 varieties and specifications, with more than 10000 upstream suppliers and 200000 downstream customers. We have obtained the qualification of national or regional distributor or agent for nearly a thousand drugs in China.

For the future, Jiuzhou Tong pointed out that it will continue to tilt towards primary healthcare institutions, further consolidating its market share in primary healthcare institutions, and the medical device sector will also continue to increase.

Source: Sina Finance